Home » Topics » BioWorld Science

BioWorld Science
RSS

Location of gene linked to type 2 diabetes discovered

Sep. 6, 1996

Clinical results for Cortecs' oral insulin formulation

Sep. 6, 1996

Terumo pursues treatments for diabetes and complications

Sep. 6, 1996

Trypsin inhibitors for pancreatitis

Sep. 6, 1996

LeukoSite awarded SBIR grant for inflammatory bowel disease research

Sep. 6, 1996

Cimetidine for treatment of interstitial cystitis

Sep. 6, 1996

Darifenacin for urge incontinence

Sep. 6, 1996

Potential use for YM-934 in bladder hypersensitivity

Sep. 6, 1996

Urethral insert approved for female stress incontinence

Sep. 6, 1996

Finasteride clinical utility continues to be debated

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...